Cargando…

PRDM16 binds MED1 and controls chromatin architecture to determine a brown fat transcriptional program

PR (PRD1–BF1–RIZ1 homologous) domain-containing 16 (PRDM16) drives a brown fat differentiation program, but the mechanisms by which PRDM16 activates brown fat-selective genes have been unclear. Through chromatin immunoprecipitation (ChIP) followed by deep sequencing (ChIP-seq) analyses in brown adip...

Descripción completa

Detalles Bibliográficos
Autores principales: Harms, Matthew J., Lim, Hee-Woong, Ho, Yugong, Shapira, Suzanne N., Ishibashi, Jeff, Rajakumari, Sona, Steger, David J., Lazar, Mitchell A., Won, Kyoung-Jae, Seale, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318146/
https://www.ncbi.nlm.nih.gov/pubmed/25644604
http://dx.doi.org/10.1101/gad.252734.114
Descripción
Sumario:PR (PRD1–BF1–RIZ1 homologous) domain-containing 16 (PRDM16) drives a brown fat differentiation program, but the mechanisms by which PRDM16 activates brown fat-selective genes have been unclear. Through chromatin immunoprecipitation (ChIP) followed by deep sequencing (ChIP-seq) analyses in brown adipose tissue (BAT), we reveal that PRDM16 binding is highly enriched at a broad set of brown fat-selective genes. Importantly, we found that PRDM16 physically binds to MED1, a component of the Mediator complex, and recruits it to superenhancers at brown fat-selective genes. PRDM16 deficiency in BAT reduces MED1 binding at PRDM16 target sites and causes a fundamental change in chromatin architecture at key brown fat-selective genes. Together, these data indicate that PRDM16 controls chromatin architecture and superenhancer activity in BAT.